| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |